Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical improvement after probiotic administration in dogs with chronic signs of colonic dysmotility without mucosal inflammatory changes - Rossi - 2020

Di uno scrittore di uomini misteriosi

Descrizione

Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical  improvement after probiotic administration in dogs with chronic signs of  colonic dysmotility without mucosal inflammatory changes - Rossi - 2020
Gut dysbiosis: Ecological causes and causative effects on human disease
Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical  improvement after probiotic administration in dogs with chronic signs of  colonic dysmotility without mucosal inflammatory changes - Rossi - 2020
Cannabinoid receptor type 1 and 2 expression in the skin of healthy dogs and dogs with atopic dermatitis in: American Journal of Veterinary Research Volume 73 Issue 7 ()
Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical  improvement after probiotic administration in dogs with chronic signs of  colonic dysmotility without mucosal inflammatory changes - Rossi - 2020
Efficacy of probiotics for managing infantile colic due to their anti- inflammatory properties: a meta-analysis and systematic review
Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical  improvement after probiotic administration in dogs with chronic signs of  colonic dysmotility without mucosal inflammatory changes - Rossi - 2020
Considering the Immune System during Fecal Microbiota Transplantation for Clostridioides difficile Infection: Trends in Molecular Medicine
Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical  improvement after probiotic administration in dogs with chronic signs of  colonic dysmotility without mucosal inflammatory changes - Rossi - 2020
Role of CB1 receptors in the acute regulation of small intestinal permeability: effects of high-fat diet
Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical  improvement after probiotic administration in dogs with chronic signs of  colonic dysmotility without mucosal inflammatory changes - Rossi - 2020
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical  improvement after probiotic administration in dogs with chronic signs of  colonic dysmotility without mucosal inflammatory changes - Rossi - 2020
Gastrointestinal dysmotility disorders in critically ill dogs and cats.
Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical  improvement after probiotic administration in dogs with chronic signs of  colonic dysmotility without mucosal inflammatory changes - Rossi - 2020
IJMS, Free Full-Text
Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical  improvement after probiotic administration in dogs with chronic signs of  colonic dysmotility without mucosal inflammatory changes - Rossi - 2020
Electroacupuncture repairs intestinal barrier by upregulating CB1 through gut microbiota in DSS-induced acute colitis, Chinese Medicine
Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical  improvement after probiotic administration in dogs with chronic signs of  colonic dysmotility without mucosal inflammatory changes - Rossi - 2020
Frontiers Probiotics, prebiotics, and synbiotics in chronic constipation: Outstanding aspects to be considered for the current evidence
Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical  improvement after probiotic administration in dogs with chronic signs of  colonic dysmotility without mucosal inflammatory changes - Rossi - 2020
Frontiers Circulating Endocannabinoids as Diagnostic Markers of Canine Chronic Enteropathies: A Pilot Study
Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical  improvement after probiotic administration in dogs with chronic signs of  colonic dysmotility without mucosal inflammatory changes - Rossi - 2020
Neonatal intestinal dysbiosis
Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical  improvement after probiotic administration in dogs with chronic signs of  colonic dysmotility without mucosal inflammatory changes - Rossi - 2020
Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical improvement after probiotic administration in dogs with chronic signs of colonic dysmotility without mucosal inflammatory changes
Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical  improvement after probiotic administration in dogs with chronic signs of  colonic dysmotility without mucosal inflammatory changes - Rossi - 2020
Potent health-promoting effects of a synbiotic formulation prepared from Lactobacillus acidophilus NCDC15 fermented milk and Cichorium intybus root powder in Labrador dogs - ScienceDirect
Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical  improvement after probiotic administration in dogs with chronic signs of  colonic dysmotility without mucosal inflammatory changes - Rossi - 2020
New Insights into the Role of Oral Microbiota Dysbiosis in the Pathogenesis of Inflammatory Bowel Disease
da per adulto (il prezzo varia in base alle dimensioni del gruppo)